Published in Cochrane Database Syst Rev on February 16, 2011
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Universal definition of myocardial infarction. Circulation (2007) 11.69
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem (2003) 8.13
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA (2007) 6.38
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34
Hypothermia therapy after traumatic brain injury in children. N Engl J Med (2008) 6.10
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93
How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med (2007) 5.86
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65
Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet (2008) 5.27
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol (2005) 4.27
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol (2009) 3.98
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
CONSORT 2010 changes and testing blindness in RCTs. Lancet (2010) 3.68
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med (2010) 3.63
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (2007) 3.51
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev (2012) 3.37
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med (2008) 3.22
EQUATOR: reporting guidelines for health research. Lancet (2008) 3.15
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther (2009) 3.15
An international registry of systematic-review protocols. Lancet (2010) 3.12
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA (2007) 3.09
Should meta-analysts search Embase in addition to Medline? J Clin Epidemiol (2003) 3.06
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol (2003) 3.02
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.00
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract (2004) 2.99
Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90
The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev (2012) 2.86
Evidence summaries: the evolution of a rapid review approach. Syst Rev (2012) 2.81
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA (2003) 2.73
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology (2003) 2.73
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Randomized trials published in some Chinese journals: how many are randomized? Trials (2009) 2.52
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Registering systematic reviews. CMAJ (2009) 2.47
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. J Evid Based Med (2010) 2.44
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
Acupuncture in poststroke rehabilitation: a systematic review and meta-analysis of randomized trials. Stroke (2010) 2.41
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Benefits and harms associated with the practice of bed sharing: a systematic review. Arch Pediatr Adolesc Med (2007) 2.34
PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med (2012) 2.31
A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals. Eval Health Prof (2002) 2.29
Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med (2008) 2.25